. 2022 Dec 15;108(5):1232–1243. doi: 10.3324/haematol.2022.281562
Copyright© 2023 Ferrata Storti Foundation
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Table 2.
Current status of eculizumab biosimilars.21-24
